通过分析其对脂肪形成的基因调控的影响，特别是对过氧化物酶体增殖物激活受体 (PPAR-g)、CCAAT/增强子结合蛋白(C/EBPa)以及STAT5A和B的影响，(±)-JQ1已被用来研究其对脂肪形成的影响。JQ1已作为BRD4化学抑制剂用于药物结合试验，以研究CRBN在小鼠和人类中的底物募集功能。 生化/生理作用： (+/-)-JQ1 是 Brd4 抑制剂。 (±)-JQ1 是 Brd4 抑制剂。已知 JQ1 抑制细胞增殖，因此，可用作编号癌症的治疗药物，包括多发性骨髓瘤和急性髓性白血病。 (±)-JQ1 has been used to study its effect on adipogenesis, by analyzing the its impact on the regulation of genes involved in this process especially peroxisome proliferator-activated receptor (PPAR-g), the CCAAT/enhancer-binding protein (C/EBPa) and, STAT5A and B. JQ1 has been used in drug binding assays as a chemical inhibitor of BRD4 to study the CRBN’s substrate recruiting function in mouse and human. Biochemical/physiological effects: (+/-)-JQ1 is a Brd4 inhibitor. (±)-JQ1 is a Brd4 inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a therapeutic drug for a number of cancers including multiple myeloma and acute myeloid leukemia.